Dark
Light
Today: July 22, 2024
December 18, 2023
1 min read

Bear Market Blues? Time to Unlock Those LPs!

TechCrunch, a leading technology media publisher, is a part of the Yahoo family of brands along with other sites and applications like Yahoo and AOL, and Yahoo Advertising. This network of sites uses cookies and other similar technologies such as web storage to provide an optimized user experience.

  • These cookies help to authenticate users, apply security measures, prevent spam and abuse, and measure the usage of the sites and apps.
  • When users click on ‘Accept all’, TechCrunch and its partners use cookies and personal data like IP addresses, location data, and browsing and search data to display personalized ads and content.
  • This data also helps measure the effectiveness of these personalized ads and helps to improve the network’s products and services.
  • Users have the option to reject all cookies and personal data usage for these additional purposes.
  • Privacy settings can be customized any time by clicking ‘Manage Privacy Settings’ or via the ‘Privacy & cookie settings’ or ‘Privacy dashboard’ links.

The use of these technologies helps read and store information from the user’s device, thereby allowing the operator to provide better services. All information related to data use is spelled out in their privacy policy and cookie policy. Thus, the usage of cookies directly correlates to providing a safe environment and personalized content to users based on their interest profiles.

This strategy also helps to correctly gauge the effectiveness of personalized ads and content, which, in turn, spurs further development and improvement of products and services. By providing easy access to privacy settings, TechCrunch ensures users have the freedom to choose and change how their data is used at any given time.

Previous Story

Biotechs end with mystery: What’s IPO-capable in today’s market?

Next Story

National Beat: VC Collapse Shakes Investors, Hoffman Talks OpenAI Chaos

Latest from Blog

Antheia Secures $17M Investment

TLDR: Antheia, a pharmaceutical ingredient manufacturer based in Menlo Park, CA, raised $17M in funding. The funding included a non-dilutive two-year project agreement up to $11M through the BioMaP Consortium. Antheia, led
Go toTop